Neuro Notes

• Secrets of a Neurology Whisperer: Talk Less, Teach More A diminished voice and potential health scare taught this neurologist that maybe less is more when it comes to teaching medical students and residents.
  Medscape Neurology, July 22, 2024
• AAN 2024 Is This Journal Legit? Open Access and Predatory Publishers Andrew Wilner, MD, interviews the editor in chief of the Neurology journals, Jose Merino, MD, on open-access publishing and the dangers of predatory journals.
  Medscape Neurology, June 20, 2024
• Posttraumatic Headache: Is Iron an Innocent Bystander?   Drs Andrew Wilner and Simona Nikolova discuss the correlation between iron accumulation and posttraumatic headache.
  Medscape Neurology, May 30, 2024
• New Brain Death Criteria: Reaching Consensus   Neurologists, Andrew Wilner and Lucas Elijovich discuss the updated guidelines on the brain death criteria and guidelines.
  Medscape Neurology, May 08, 2024
• Alzheimer's Disease vs Dementia: Nomenclature Matters   Terms such as dementia, Alzheimer's disease, and frontotemporal dementia are inconsistently used. Neurologists Andrew Wilner and Ron Petersen discuss a new framework for dementia nomenclature.
  Medscape Neurology, February 21, 2024
• Alzheimer's Disease and Epilepsy: New Clues to the Link   Dr Andrew Wilner interviews Dr Christos Lisgaras about his research exploring the link between epileptic seizures and Alzheimer's disease, recently presented at the American Epilepsy Society meeting.
  Medscape Neurology, February 08, 2024
• Hyperbaric Oxygen Therapy for TBI: Wishful Thinking? A recent review recommending HBOT for traumatic brain injury prompted this neurologist to revisit a treatment he trained in decades ago.
  Medscape Neurology, September 22, 2023
• New DEA CME Mandate Affects Two Million Prescribers Are you affected by new CME requirements that go into effect on June 27, 2023? Dr Andrew Wilner explains the implications.
  Medscape Neurology, June 26, 2023
• What to Expect in the New Concussion Guidelines   Andrew N. Wilner, MD, and Shae Datta, MD, discuss recent developments in sports neurology.
  Medscape Neurology, May 17, 2023
• Virtual Reality in ASD: From Second Life to Real Life   Andrew Wilner, MD, asks medical student Dana Allison about her review of virtual-reality interventions for autistic spectrum disorder presented at the 2023 American Academy of Neurology meeting.
  Medscape Neurology, May 10, 2023
• Posttraumatic Headache: What Works, What Doesn't   Andrew Wilner, MD, and Nina Riggins, MD, PhD, discuss how to treat posttraumatic headache and when it's safe to do so.
  Medscape Neurology, May 03, 2023
• Standalone Video Review for Diagnosing Seizures   Andrew N. Wilner, MD, and Selim Benbadis, MD, discuss the use of video for diagnosing seizures.
  Medscape Neurology, March 03, 2023
• A Revolution in the Treatment Landscape of AD   Andrew N. Wilner, MD, and Richard J. Caselli, MD, discuss developments in the treatment of Alzheimer's disease.
  Medscape Neurology, March 02, 2023
• Epilepsy in Nursing Homes: The Need for Education   Andrew N. Wilner, MD, and Ilo E. Leppik, MD, discuss research presented at the American Epilepsy Society meeting.
  Medscape Neurology, March 01, 2023
• Cannabidiol for Absence Epilepsy: More to Learn   Andrew N. Wilner, MD, and Selim Benbadis, MD, discuss cannabidiol for absence epilepsy.
  Medscape Neurology, February 28, 2023
• What Tops an EEG for Epilepsy Diagnosis?   Andrew N. Wilner, MD, and Jacqueline French, MD, discuss the diagnosis of epilepsy and the use of remote adjudication of patients in clinical trials.
  Medscape Neurology, February 27, 2023
• The Impact of Social Determinants of Health on Epilepsy Treatment   Andrew N. Wilner, MD, and Joseph I. Sirven, MD, discuss the impact of social determinants of health on epilepsy.
  Medscape Neurology, January 30, 2023
• Neurologic Symptoms in People With Long COVID   Dr Andrew Wilner and Dr Igor Koralnik discuss the range of neurologic symptoms that can persist after acute COVID-19.
  Medscape Neurology, December 22, 2022
• Starting Lamotrigine: Who Needs an EKG?   Drs Wilner and French discuss the latest FDA label changes on lamotrigine and what they mean in practice.
  Medscape Neurology, November 22, 2022
• Long-Acting, Subcutaneous Levodopa In Parkinson's Disease: Is It Safe?   Priming the pump in Parkinson's disease -- a new levodopa solution. Join Dr Andrew Wilner as he discusses the safety of this new method of administration with Dr Jason Aldred.
  Medscape Neurology, September 07, 2022